Literature DB >> 17153543

A lower-limb functional capacity test for enlistment into Swedish Armed Forces ranger units.

Helena Larsson1, Karin Harms-Ringdahl.   

Abstract

The present work validated minimal performance standards for a lower-limb functional capacity test used at enrollment to predict the risk of discharge from strenuous military ranger training in the Swedish Armed Forces. To set a relevant level of performance, trained conscripts in a ranger unit (n = 38) performed a maximal physical fitness test, including the newly developed ranger test, during the last week of their 1-year basic training. The following year, basic training started with an initial strength test performed by all conscripts (n = 285). They performed the ranger test as a submaximal one. The relative risk was high (risk ratio, 48.5) for discharge attributable to knee problems for conscripts who failed the submaximal ranger test during the initial strength test. The area under the receiver operating characteristic curve was 0.91 (SE, 0.09) for failing the test. The submaximal ranger test had a high discriminating ability and predictive value for discharge caused by knee problems.

Mesh:

Year:  2006        PMID: 17153543     DOI: 10.7205/milmed.171.11.1065

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  Content Validity Index and Intra- and Inter-Rater Reliability of a New Muscle Strength/Endurance Test Battery for Swedish Soldiers.

Authors:  Helena Larsson; Matthias Tegern; Andreas Monnier; Jörgen Skoglund; Charlotte Helander; Emelie Persson; Christer Malm; Lisbet Broman; Ulrika Aasa
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

2.  A longitudinal observational study of back pain incidence, risk factors and occupational physical activity in Swedish marine trainees.

Authors:  Andreas Monnier; Helena Larsson; Håkan Nero; Mats Djupsjöbacka; Björn O Äng
Journal:  BMJ Open       Date:  2019-05-14       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.